MVision AI Receives MFDS Approval and Market Authorization for South Korea
HELSINKI, Finland – June 14, 2024 MVision AI is pleased to announce that our application for MVision AI Segmentation (Contour+) in South Korea has been accepted by the Ministry of Food and Drug Safety (MFDS) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation therapy treatment planning workflows. This […]
From Awareness to Action: International Men’s Health Week and Cancer Screening
This year, from 10 to 16 June we celebrate the International Men’s Health Week. The dates are different each year, so it precedes and includes Father’s Day. Multiple activities around the world aim to raise awareness of men’s preventable health problems and early detection (1). The official framework was created in 1994 and got to […]
Refining Volumes – a Study on Cardiac Substructures’ Impact on Survival in Lung Cancer Patients Treated with Radiation Therapy
Cardiac diseases and cancers are leading causes of death [1]. Many cancer patients have preexistent cardiac impairment or have risk factors of developing it. On the other hand, survival after being diagnosed with cancer is increasing, so relatively more patients may develop long-term side effects. Cardiac diseases and cancers are leading causes of death [1]. […]
Personalised AI radiotherapy ROIs at your fingertips
MVision’s configuration solution (ConfigUI) introduces advanced region of interest (ROI) operations and smart post-processing options to support multiple clinical scenarios and complex treatment planning workflows. MVision Contour+ offers an impressive number of structures (more than 270), based on organs or anatomically defined regions, such as lymph node levels. However, we acknowledge that clinical practice requires […]
MVision AI receives TGA approval and market authorization for Australia
HELSINKI, Finland – May 1, 2024 An application for MVision AI Segmentation (Contour+) has been submitted and accepted by the Therapeutic Goods Administration (TGA) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation therapy treatment planning workflows. Contour+ accelerates the contouring process, provides guidance toward standardization, enhances consistency, and […]
Dharanipathy Rangaraj Appointed as CEO of MVision AI
Helsinki, Uusimaa – April 29, 2024 – MVision AI, a pioneering company in developing innovative AI solutions in the radiation oncology & imaging space, proudly announces the appointment of Dharanipathy Rangaraj as its new Chief Executive Officer (CEO). In his new capacity as CEO of MVision AI, Dharani will spearhead the company’s mission of developing […]
MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON)
Finland, Helsinki, February 19, 2024 The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI’s successful award of the tender from the Republic of Ireland’s Health Service Executive […]
MVision AI Announces Partnership with Medron Medical Systems (Canada)
HELSINKI, Finland – January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL) approval from Health Canada. The […]
The world’s first comprehensive GBS™ solution for radiation therapy cancer treatment is now available for implementation in Canadian clinics
HELSINKI, Finland – January 22, 2024 MVision AI announces first Health Canada Medical Device License for MVision AI Segmentation (Contour+). In conjunction with Guide and Verify, Contour+ stands as a unique solution covering all the essential needs of radiotherapy departments, offering a more comprehensive approach to staff training and patient treatment plans. According to the […]
The voice of customer experience: Dr. Giuseppe Sasso, New Zealand
Dr. Giuseppe Sasso is a Radiation Oncologist with extensive experience in the field, who has been using MVision AI for more than a year already, as an individual customer. He graduated from University of Naples where he also finished residency training 25 years ago. Since then, he has treated patients in multiple clinics from Italy, […]
Merging (Artificial) Intelligence and Ethics in Radiation Oncology – Why and How?
”Our future is a race between the growing power of technology and the wisdom with which we use it.” This statement of Stephen Hawking, the well known physicist, mathematician and visionary, summarizes very well the present challenges. A new technology, irrespective of its degree of complexity, makes an impact in our world depending on the […]
LEARN. PREVENT. SCREEN. CERVICAL CANCER CAN BECOME HISTORY.
January is Cervical Cancer Awareness Month, and these three core principles are emphasized during the 2024 campaign. Nowadays, cervical cancer is responsible for more than 300,000 deaths each year globally. Fortunately, we have the tools to prevent it, diagnose it early, and treat it efficiently in most cases. This is why we need to become […]
